Anthony, Have you written a bioregulator book or have a training course?

The idea that “BPC-157 feeds cancer” sounds convincing at first because it leans on a real biological truth, but then stretches that truth past where the evidence actually goes. To understand what is really happening, you have to zoom out and look at how the body makes decisions at the cellular level. Cells are not blindly following one signal. They are constantly integrating multiple inputs, like a control center weighing oxygen levels, damage signals, inflammation, energy status, and structural integrity. BPC-157 seems to operate inside that decision-making network, not as a simple on/off switch for growth. Let’s start with the fear itself. VEGF is a real molecule with a real job. It stands for vascular endothelial growth factor, and its role is to help build blood vessels. If tissue is injured or deprived of oxygen, VEGF helps recruit new blood supply. Tumors can hijack this system. They release VEGF to grow their own blood supply, which helps them expand. That part is not controversial. The mistake happens when people assume that anything touching VEGF automatically behaves like VEGF. That is like assuming that anyone who walks into a construction site is a construction worker. Some people are there to build. Others are there to supervise, clean up, or shut things down. BPC-157 looks much more like a coordinator than a builder. At a molecular level, true angiogenic drivers like VEGF-A, FGF-2, or PDGF act as primary signals. They bind directly to receptors like VEGFR2 and initiate a cascade that pushes endothelial cells to proliferate, migrate, and form new vessel structures. This involves pathways like MAPK/ERK for proliferation, PI3K/Akt for survival, and eNOS activation for nitric oxide production and vessel dilation. When these signals are sustained, you get continuous vessel growth. That is exactly what tumors exploit. BPC-157 does not appear to behave like that. In resting endothelial cells, meaning cells that are not experiencing injury or stress, BPC-157 does not trigger angiogenesis. No tube formation, no forced proliferation, no “build vessels now” signal. That alone separates it from classic tumor-supporting growth factors.

I got the ketone-IQ that @Anthony Castore has talked about. Was shopping and saw it in the store. Feeling a little out of it today, dragging my a$#. Wrkg long hours. Question - Can I do my Lipo Amino Acid Vit B injections and still drink the ketone iq? Would that be overkill... should I do them on separate days?